47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -42,3 | |||
Gross profit (loss) | -0,1 | -0,2 | -0,5 | -100,6 |
EBITDA | -68,9 | |||
Short time liabilities | 7,5 | |||
Income tax | 0 | -0 | -0,1 | -1040,1 |
Other operating costs | -23,8 | |||
Equity capital | -0,6 | -0,8 | -1,2 | -50,5 |
Operating profit (EBIT) | -46,7 | |||
Assets | 0,3 | 0,4 | 14,5 | 3388,2 |
Net profit (loss) | -0,1 | -0,2 | -0,4 | -79,1 |
Cash | 64,6 | |||
Net income from sale | -5,3 | |||
Liabilities and provisions for liabilities | 0,9 | 1,2 | 15,7 | 1199,4 |
Working assets | 0,2 | 0,4 | 0,3 | -1,8 |
Other income costs | -72,5 | |||
Basic operational activity income | 1,2 | 1,4 | 1,5 | 11,1 |
Depreciation | -4,8 | |||
% | % | % | p.p. | |
Profitability of capital | 1,3 | |||
Equity capital to total assets | -198,4 | -190,5 | -8,2 | 182,3 |
Gross profit margin | -11,1 | -16,8 | -30,3 | -13,5 |
EBITDA Margin | -1,5 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 21 | |||
Current financial liquidity indicator | 0 | |||
Net dept to EBITDA | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane